Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The information provided should not be used for diagnosing or treating a health condition. Always consult your healthcare provider before starting, stopping, or changing any medication or treatment plan. Individual results may vary.
Insomnia is not listed among the common adverse reactions in the prescribing information for Zepbound, Mounjaro, Wegovy or Ozempic. Of the six GLP-1 labels we checked (those four plus Saxenda and Rybelsus), only Saxenda (liraglutide) lists it: 2.4% of adults on Saxenda reported insomnia, against 1.7% on placebo.
That does not mean your sleepless nights are imaginary. The labeled side effects that do happen often, such as nausea, reflux and, for some people, low blood sugar, can all show up at night. This page covers what each label says, what is worth ruling out, what helps, and when to call.
Is insomnia a side effect of Zepbound? What each label says
From the current US prescribing information for each drug:
| Drug | Insomnia in the adverse reactions table? | Placebo |
|---|---|---|
| Zepbound (tirzepatide) | Not listed in the label's common adverse reactions table (Table 1, reactions in ≥2% and more than placebo) | — |
| Mounjaro (tirzepatide) | Not listed in the label's common adverse reactions table (Table 1, reactions in ≥5%) | — |
| Wegovy (semaglutide) | Not listed in the label's common adverse reactions table (Table 3, reactions in ≥2% and more than placebo) | — |
| Ozempic (semaglutide) | Not listed in the label's common adverse reactions table (Table 1, reactions in ≥5%) | — |
| Saxenda (liraglutide) | 2.4% of adults (Table 2, reactions in ≥2% and more than placebo) | 1.7% |
The Zepbound and Mounjaro labels do not mention insomnia in their post-marketing sections either. So the honest answer to "does tirzepatide cause insomnia" is that the trials behind the label did not find it as a common side effect. Labels for Mounjaro and Ozempic only list reactions seen in at least 5% of people, so a rarer effect could sit below that line. Full lists are on the Zepbound side effects and Saxenda side effects pages, and every symptom is compared in the GLP-1 side effects hub.
Zepbound and sleep apnea: a separate fact
Zepbound has a second approved use: to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity, alongside a reduced-calorie diet and more physical activity. Sleep apnea is a breathing disorder during sleep. It is not the same thing as insomnia.
In the two 52-week sleep apnea trials in the label (Studies 5 and 6), the apnea-hypopnea index (breathing pauses per hour) fell by about 25 to 29 events per hour on Zepbound, against about 5 on placebo. People on Zepbound in those trials also reported less sleep-related impairment than people on placebo. Those results apply to people with diagnosed OSA. They do not tell you how Zepbound affects sleep in general.
Why can't I sleep on Zepbound or Ozempic?
No label describes a mechanism by which tirzepatide or semaglutide causes insomnia, and we will not invent one. What the labels do document are side effects that can make a night worse:
- Nausea and indigestion. In the Zepbound weight trials, nausea affected 25–29% of people (8% on placebo) and dyspepsia 9–10% (4% on placebo). See the nausea guide.
- Reflux. Gastroesophageal reflux disease was reported by 4–5% on Zepbound versus 2% on placebo. The NIDDK notes that if reflux comes at night or when lying down, finishing meals at least 3 hours before bed may help.
- Low blood sugar. The labels warn that taking a GLP-1 with insulin or a sulfonylurea raises the risk of hypoglycemia. The Wegovy Medication Guide lists signs that include sweating, shakiness, a fast heartbeat, anxiety and hunger.
- Ordinary sleep disruptors. The CDC advises against caffeine in the afternoon or evening, and against large meals and alcohol before bed. Stress also raises insomnia risk, according to the NHLBI.
Some people also notice that they eat very little during the day on a GLP-1 and then wake up hungry. No published data shows this for these drugs, but it is easy to check in your own log.
When does it start, and how long does it last?
No label or trial gives a timeline for sleep trouble on these drugs. For insomnia in general, the NHLBI describes short-term insomnia as lasting a few days or weeks. Chronic insomnia is defined as 3 or more nights a week for more than 3 months.
If your bad nights cluster in the first days after each shot, or after a dose increase, a two-to-three-week log will show it. That pattern is useful to your prescriber, because it ties the symptom to the medication rather than to everything else going on.
What helps with insomnia on a GLP-1
- Keep a fixed bedtime and wake time, even on days off. This is the CDC's first sleep tip.
- Move caffeine earlier. Avoid coffee, tea, energy drinks and pre-workout products in the afternoon and evening.
- Finish dinner earlier if reflux or nausea wakes you. Aim for at least 3 hours between your last meal and lying down. Keep the evening meal smaller and lower in fat. The NIDDK also suggests raising your head and upper back 6 to 8 inches with a foam wedge.
- Eat enough during the day. Spread protein across meals so you are not running on empty at bedtime. The protein calculator gives a daily target, and what to eat on Zepbound has easy options.
- Go easy on evening alcohol. The CDC lists alcohol before bed as something to avoid. Read more on drinking alcohol on a GLP-1.
- Put screens away 30 minutes before bed, as the CDC recommends.
- Ask your prescriber before taking a sleep aid, including melatonin, antihistamines or magnesium supplements, and before changing your injection day or time. The labels let you inject at any time of day, but a change to your routine is still worth discussing. Never skip, delay or change a dose to fix sleep.
When to call your doctor
Contact your prescriber promptly if:
- You take insulin or a sulfonylurea and wake up sweaty, shaky, confused or with a racing heart. These are listed signs of low blood sugar. Check your glucose if you can.
- Pain keeps you awake, especially severe stomach pain that does not go away, with or without vomiting, or pain that spreads to your back (a labeled sign of pancreatitis), or pain in the upper right belly (gallbladder).
- You cannot keep fluids down or have signs of dehydration, which the labels warn can lead to kidney problems.
- Poor sleep lasts more than a few weeks, or you snore loudly or stop breathing in your sleep, which can be sleep apnea.
- Poor sleep comes with low mood, anxiety or thoughts of harming yourself. Seek help the same day; in the US you can call or text 988. See mood, anxiety and depression.
Tiredness during the day after bad nights is common. Daytime exhaustion that does not lift is covered in the fatigue guide.
What to track (and why it helps)
The NHLBI notes that a provider may ask you to keep a sleep diary to diagnose insomnia. In GLP AI, insomnia is an item in the side-effect catalog, and each entry gets a severity from 1 to 10. Log it the morning after a bad night, next to your shot days and meals.
The estimated medication level chart puts those entries against the point in your dose week, so you can see whether bad nights follow the shot. Logging dinner time and size shows whether late or heavy meals line up with bad nights. When you see your prescriber, export the doctor report: a PDF of your medication history, side effects, nutrition and weight over time that you share yourself. The GLP-1 symptom tracker and doctor visit prep pages explain how.
Zepbound Insomnia FAQ
Does Zepbound cause insomnia?
Insomnia is not listed among the common adverse reactions in the Zepbound prescribing information, which lists reactions seen in at least 2% of people and more often than on placebo. Labeled side effects such as nausea, reflux and, with insulin or a sulfonylurea, low blood sugar can still disturb sleep. Tell your prescriber if poor sleep continues.
Does tirzepatide cause insomnia?
Neither tirzepatide label (Zepbound or Mounjaro) lists insomnia in its adverse reactions table or post-marketing section. Zepbound is approved to treat moderate to severe obstructive sleep apnea in adults with obesity, which is a different sleep condition.
Does Wegovy cause sleep problems?
Insomnia is not listed in the Wegovy label's common adverse reactions table. Of the six GLP-1 labels we checked, only Saxenda (liraglutide) lists it: 2.4% of adults versus 1.7% on placebo.
Why can't I sleep on Ozempic?
The Ozempic label does not list insomnia. Common reasons for poor sleep on any GLP-1 include nausea or reflux at night, a late or heavy dinner, caffeine later in the day, alcohol, and stress. Logging your nights next to your shot days shows whether there is a pattern to discuss with your prescriber.
Can I take melatonin or a sleep aid with Zepbound?
Ask your prescriber or pharmacist before you take any sleep aid, including over-the-counter products and supplements. They can check it against your other medicines and health conditions.
Sources verified 2026-10-26
- Zepbound prescribing information (USPI, revised 08/2026) — Indications (OSA), section 2 (any time of day), 5.7 Hypoglycemia, Table 1 adverse reactions, 6.2 Postmarketing, 14.2 OSA Studies 5 and 6 (Table 9, sleep-related impairment).
- Mounjaro prescribing information (USPI, revised 08/2026) — Table 1 adverse reactions (≥5%), 6.2 Postmarketing.
- Wegovy prescribing information and Medication Guide — Table 3 adverse reactions, hypoglycemia warning, Medication Guide signs of low blood sugar.
- Ozempic prescribing information — Table 1 adverse reactions (≥5%).
- Saxenda prescribing information — Table 2: insomnia 2.4% (Saxenda) vs 1.7% (placebo).
- CDC — About Sleep — sleep habits: schedule, screens, meals, alcohol, caffeine.
- NHLBI — Insomnia and Insomnia causes and risk factors — short-term vs chronic insomnia, sleep diary, stress and caffeine.
- NIDDK — Eating, diet and nutrition for GER and GERD and Treatment for GER and GERD — meals 3 hours before bed, raising the head of the bed.
GLP AI
Editorial
Educational content from the GLP AI team about living on a GLP-1. Clinical review is credited by name on pages a reviewer has checked. Not medical advice.
More GLP-1 side effects
- Nausea & vomitingGLP-1 nausea is the most common side effect: 25–29% on Zepbound and 44% on Wegovy vs 8–16% on placebo. Why it happens, how long it lasts, what helps.
- ConstipationGLP-1 constipation: 11–24% of people on Zepbound or Wegovy in weight-loss trials vs 5–11% on placebo. Fiber and fluid targets, what helps, when to call.
- DiarrheaHow common it is on Zepbound, how long it lasts, what helps and when to call.
- Hair lossGLP-1 hair loss is in the labels: 4–5% on Zepbound and 3% on Wegovy 2.4 mg, vs 1% on placebo. Why it happens, when it regrows, and when to call.
- Fatigue & tirednessDoes GLP-1 make you tired? Fatigue is a labeled side effect: 5–7% on Zepbound, 11% on Wegovy, vs 3–5% on placebo. Causes, what helps, when to call.
- Muscle loss & muscle painGLP-1 muscle loss: about a quarter of the weight lost on tirzepatide in trials was lean mass. How protein and strength training help, and muscle pain.
- Injection site reactionsA Zepbound injection site reaction (redness, itching, bruising) affected 6–8% of people vs 2% on placebo. What helps, and the allergy signs that need care.
- HeadacheTirzepatide headache: Zepbound and Mounjaro labels don't list it; Wegovy lists 14% vs 10% on placebo. Common triggers, what helps, when to get help.
- Sulfur burpsSulfur burps on Wegovy, Ozempic, Zepbound or Mounjaro: belching is in every label (up to 7% vs under 1% on placebo). Why, what helps, when to call.
- DizzinessGLP-1 dizziness is a labeled side effect: 8% on Wegovy vs 4% on placebo, 4–5% on Zepbound vs 2%. Common causes to rule out, what helps, when to call.
- Period changesGLP-1 and periods: no label lists cycle changes, but tirzepatide can make the pill less effective. What each label says, and when to call.
- Back painZepbound back pain: no GLP-1 label lists it as a common side effect, but belly pain that spreads to the back is the pancreatitis warning sign.
- Mood, anxiety & depressionCan tirzepatide cause anxiety? Its labels don't list anxiety or depression, and a 2026 FDA review found no added risk. What to know and when to get help.

